Author information

1

From the Center for Human Genetic Research (T.W.K.B., V.V., S.B.K., C.K., C.D.A., G.J.F., J.R.), Division of Neurocritical Care and Emergency Neurology (T.W.K.B., C.K., C.D.A., G.J.F., J.R.), and Department of Neurology (F.J.M.), Massachusetts General Hospital, Boston; Program in Medical and Population Genetics, Broad Institute, Cambridge (T.W.K.B., C.K., C.D.A., G.J.F., J.R.); School of Systems Biomedical Science, Soongsil University, Seoul, South Korea (C.L.); Department of Neurology, Institut Hospital del Mar d'Investigacions Mèdiques, Universitat Autonoma de Barcelona, Barcelona, Spain (J.J.-C.); Stroke Pharmacogenomics and Genetics Fundacio Docencia i Recerca MutuaTerrassa, Hospital Mutua de Terrassa, Terrassa, Spain (I.F.-C.); Department of Pathology and Molecular Medicine, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada (G.P.); Miller School of Medicine, University of Miami (T.R.); Departments of Anesthesiology and Neurology, Duke University, Durham (M.L.J.); Department of Neurosciences, VIB-Vesalius Research Center, Experimental Neurology-Laboratory of Neurobiology, KU Leuven, University of Leuven, Leuven, Belgium (R.L.); Department of Neurology, University Hospitals Leuven, Leuven, Belgium (R.L.); Department of Neurology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan (T.-H.L.); Department of Neurology, Helsinki University Central Hospital, Helsinki, Finland (T.T.); Department of Neurology, Veterans Administration Medical Center and University of Maryland School of Medicine, Baltimore (S.J.K.); Department of Clinical Sciences, Neurology, Lund University and Department of Neurology and Rehabilitation Medicine, Skåne University Hospital, Lund, Sweden (A.L.); Department of Neurology, Brigham and Women's Hospital, Boston (A.L.B.); School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia (E.G.H.); Hunter Medical Research Institute, Newcastle, New South Wales